Skip to main content
Log in

Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults

  • Original Articles
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia. During the first induction therapy a double-blind, randomized and placebo-controlled study was undertaken. Fifty-two patients were treated with 200 mg acyclovir orally four times daily throughout the induction period, whereas 55 patients received placebo. The groups were comparable with regard to age, cytotoxic chemotherapy and duration of neutropenia. Bacteraemias were significantly fewer in the acyclovir group (20 versus 41 episodes; P=0.007). The number of isolated microorganisms causing bacterial or fungal infections was also lower during acyclovir prophylaxis (52 isolates, versus 93 isolates; P=0.02). There was no significant differenc between the groups with regard to the number of clinically documented infections or fevers of unknown origin. Herpes simplex virus isolations occurred only in the placebo group (P=0.001). Thus, oral acyclovir prophylaxis was associated with reductions of all microbiologically documented infections suggesting that prevention of herpes simplex virus reactivation in acute leukaemia patients may reduce the occurrence of other infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abramson JS, Mills EL (1988) Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis 10:326–341

    Google Scholar 

  2. Anderson H, Scarffe JH, Sutton RNP, Hickmott E, Brigden D, Burke C (1984) Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukemia patients receiving remission induction therapy. A randomised double blind, placebo controlled trial. Br J Cancer 50:45–49

    Google Scholar 

  3. Buss DH, Scharyj M (1979) Herpesvirus infection in esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med 66:457–462

    Google Scholar 

  4. EORTC (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytic patients with cancer. J Infect Dis 137:14–29

    Google Scholar 

  5. Gale RP, Cline MJ (1977) High remission induction rate in acute leukaemia. Lancet I:497–499

    Google Scholar 

  6. Gerson SL, Friedman HM, Cines DB (1985) Viral infection of vascular endothelial cells alters production of colony-stimulating activity. J Clin Invest 76:1382–1390

    Google Scholar 

  7. Gluckman E, Devergie A, Melo R, Nebout T, Lotsberg J, Zhao XM, Gomez-Morales M, Mazeron MC (1983) Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet II:706–708

    Google Scholar 

  8. Hann IM, Prentice HG, Blacklock HA, Ross MGR, Brigden D, Rosling AE, Burke C, Crawford DH, Brumfitt W, Hoffbrand AV (1983) Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J 287:384–388

    Google Scholar 

  9. Heimdahl A, Mattsson T, Dahllöf G, Lönnqvist B, Ringdén O (1989) The oral cavity as a portal of entry for local and systemic early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68:711–716

    Google Scholar 

  10. Lam MT, Pazin GJ, Armstrong JA, Monto HO (1981) Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study. Cancer 48:2168–2171

    Google Scholar 

  11. Leynette E, Balows A, Hauser W Jr, Shadowy HJ (eds) (1980) Manual of clinical microbiology, 3rd edn. American Society of Microbiology, Washington, DC

    Google Scholar 

  12. Lundgren G, Wilczek H, Lönnqvist B, Lindholm A, Wahren B, Ringdén O (1985) Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl 47:137–144

    Google Scholar 

  13. Newman KA, Schimpff SC, Young VM, Wiernik PH (1981) Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research. Am J Med 70:423–431

    Google Scholar 

  14. Palmblad J, Lönnqvist B, Carlsson B, Grimfors G, Järnmark M, Lerner R, Ljungman P, Nyström-Rosander C, Petrini B, Öberg G (1992) Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteriaemias. J Intern Med 231:363–370

    Google Scholar 

  15. Paul C, Tidefelt U, Gahrton G, Björkhlm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt A-M, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å (1991) A randomized comparison of doxorubicin and doxorubicin-DNA in the treatment of acute non lymphoblastic leukemia. Leukemia Lymphoma 3:355–364

    Google Scholar 

  16. Pizzo PA, Robichaud KJ, Edwards BK, Schumaker C, Kramer BS, Johnson A (1983) Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr 102:125–133

    Google Scholar 

  17. Ringdén O, Heimdahl A, Lönnqvist B, Malmborg A-S, Wilczek H (1984) Decreased incidence of Viridans streptococcal septicemia in allogenic bone marrow transplant recipients after the introduction of acyclovir. Lancet I:744

    Google Scholar 

  18. Rouse BT, Horohov DW (1986) Immunosuppression in viral infections. Rev Infect Dis 8:850–873

    Google Scholar 

  19. Sánches-Fayos J, Outeirino E, Villalobos C, Paniagua C, Calabuig T, Lite M, Figuera A, Pérez-Rus G, Prieto E, Serrano J, Escudero A (1985) Acute lymphoblastic leukaemia in adults: results of a “total-therapy” programme in 47 patients over 15 years old. Br J Haematol 59:686–696

    Google Scholar 

  20. Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS (1981) Acyclovir prophylaxis of herpes-simplex-virus infections. A randomized, double-blind, controlled trial in bonemarrow-transplant recipients. N Engl J Med 305:63–67

    Google Scholar 

  21. Saral R, Ambinder RF, Burns WH, Angelopoulos CM, Griffin DE, Burke PJ, Lietman PS (1983) Acyclovir prophylaxis against herpex simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med 99:773–776

    Google Scholar 

  22. Schimpff SC (1981) Surveillance cultures. J Infect Dis 144:81–84

    Google Scholar 

  23. Sundqvist V-A, Linde A, Wahren B (1984) Virus-specific immunoglobulin G subclasses in herpes simplex and varicallazoster virus infections. J Clin Microbiol 20:94–98

    Google Scholar 

  24. Wade JC, Newton B, Flournoy N, Meyers JD (1984) Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100:823–828

    Google Scholar 

  25. Wong K, Hirsch MS (1984) Herpes virus infections in patients with neoplastic disease. Am J Med 75:464–478

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

The following investigators participated in this study: Magnus Björkholm, Karl Merk, Anders Åhre, Department of Medicine, Danderyd Hospital, Danderyd; Lars Engstedt, Ann-Maria Udén, Department of Medicine, Stockholm Söder Hospital, Stockholm; Gösta Gahrton, Ragnhild Lindquist, Dieter Lockner, Christer Paul, Department of Medicine, Huddinge Hospital, Huddinge; Andreas Killander, Bengt Simonsson, Department of Medicine, University Hospital, Uppsala; Bengt Wadman, Ann-Marie Stalfelt, Department of Medicine, Medical Centre Hospital, Örebro; Christer Sundström, Department of Pathology, University Hospital, Uppsala; Åke Öst, Department of Pathology, Karolinska Hospital, Stockholm; Bo Johansson, Christina Simonsson-Lindemalm, Håkan Mellstedt, Christina Wedelin, Radiumhemmet, Karolinska Hospital, Stockholm

About this article

Cite this article

Lönnqvist, B., Palmblad, J., Ljungman, P. et al. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. Support Care Cancer 1, 139–144 (1993). https://doi.org/10.1007/BF00366060

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00366060

Key words

Navigation